The Cochrane Collaboration Establishes Representation in Colombia Why and for What Purpose?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Cochrane Afraid to Challenge the Diagnostic Acu- Men Ofhis Ancestors Or Peers
place or at the wrong time. He was not The Cochrane afraid to challenge the diagnostic acu- men ofhis ancestors or peers. He Collaboration believed that clinical questions often were answered on the basis oftests, Lessons for Public Health rather than on common sense. Practice and Evaluation? Obstetrics offered Cochrane an example ofthe practices ofthe day. Like many other fields ofmedicine, MIRUAM ORLEANS, PHD obstetrics adhered to treatments that perhaps were oftraditional or emo- tional value but which had little basis Archie Cochrane undoubtedly in science. The therapeutic use ofiron wanted to reach providers of and vitamins, the basis for extended health care with his ideas, but he lengths ofstay in hospitals following probably never thought that he would childbirth, and the basis for deciding father a revolution in the evaluation of how many maternity beds were needed medical practices. in Britain were all questioned by In his book ofonly 92 pages, Cochrane, who believed that these "Effectiveness and Efficiency: Random matters could and should be investi- Reflections on Health Services," pub- gated in trials. lished by the Nuffield Provincial Hos- Although Cochrane was by no pitals Trust in 1972, he cast a critical means the first clinician-epidemiologist eye on health care delivery, on many to suggest that randomized controlled A. L Cochrane well-respected and broadly applied trials were an appropriate means of interventions, and on whole fields of deciding questions regarding the effi- were appropriate for laboratory studies medicine and their underlying belief ciency and benefit oftreatment, I can and probably some animal and behav- systems (1). -
The Cochrane Collaboration: an Introduction P
toolbox research are unlikely to have a high ticular research questions. This is why become dated and irrelevant. Because of number of clinically based trials direct the evidence-based supplement will also this we will seek to both review our core ed towards them. Equally journals endeavour to include these when appro list regularly and also look beyond this which publish qualitative research are priate and well conducted. list. If any reader feels any particular disadvantaged in a table based on ran It is equally important that only well article is important and should be domised-controlled trials or systematic conducted and reported randomised included please feel free to contact the review. However rating journals on the controlled trials or systematic reviews editorial office with the reference. We basis of their number of citations is are included. If we were to look in detail will then include it in our review equally open to challenge as noted at both the randomised-controlled tri process. Provided it passes the quality above. als and systematic reviews identified by filters it will appear in the supplement. Well-conducted randomised -con- the search strategy above many would trolled trials and systematic reviews not meet our quality criteria (see page Acknowledgements based on them have great potential for 32). This supplement will endeavour to To Christine Allot, Librarian, at the Berkshire Health Authority who conducted the answering questions about whether a include only good quality articles relat medline searches. treatment does more harm than good ing to treatment, diagnostic testing, particularly in the clinical situation. -
SURE Guides for Preparing and Using Evidence-Based Policy Briefs 1
SURE Guides for Preparing and Using Evidence-Based Policy Briefs 1. Getting started Version 2.1 – Updated November 2011 The SURE Collaboration Suggested citation The SURE Collaboration. SURE Guides for Preparing and Using Evidence-Based Policy Briefs: 1. Getting started. Version 2.1 [updated November 2011]. The SURE Collaboration, 2011. Available from www.evipnet.org/sure Copyright You are free to use, distribute and reproduce this work provided the source is properly cited. You may not use this work for commercial purposes without the permission of the SURE Collaboration. SURE is a collaborative project that builds on and supports the Evidence-Informed Policy Network (EVIPNet) in Africa and the Regional East African Community Health (REACH) Policy Initiative. The project involves teams of researchers and policymakers in seven African countries and is supported by research teams in three European countries and Canada. SURE is funded by the European Commission’s 7th Framework Programme (Grant agreement no 222881). Web address: www.evipnet.org/sure Email address: [email protected] 1 1. Getting started 2 Summary In this guide we describe what an ‘evidence-based policy brief’ is, what should be included in such a document, the ways in which it can be used, and the first steps required when preparing one. • What is a policy brief? • What should be included in a policy brief? • How can policy briefs be used? • First steps This guide also includes additional resources for developing a plan to build the capacity needed to prepare and support the use of policy briefs. Resources are also provided for the preparation of rapid responses for policymakers in circumstances in which they may need research evidence but there is insufficient time to prepare a policy brief, or in instances when there is no need to prepare one. -
Evaluation of NIHR Investment in Cochrane Report
Evaluation of NIHR investment in Cochrane infrastructure and systematic reviews Committee members: Professor Jos Kleijnen (Chair), Dr Phil Alderson, Dr Jane Aubin, Professor John Cairns, Ms Sally Crowe, and Professor Paul Garner Report writer: Kate Misso 10 February 2017 1 TABLE OF CONTENTS LIST OF TABLES ............................................................................................................................ 5 LIST OF FIGURES ........................................................................................................................... 6 LIST OF ABBREVIATIONS ............................................................................................................... 7 EXECUTIVE SUMMARY ............................................................................................................... 10 1. The global landscape of systematic reviews ............................................................................. 10 2. The performance of NIHR funded Cochrane Review Groups (CRGs) ....................................... 11 3. Cochrane’s impact on key clinical and policy issues in the NHS ............................................... 13 4. The economic impact of systematic reviews ............................................................................ 14 5. Current and planned developments in Cochrane and stakeholders’ views ............................. 14 Conclusions ...................................................................................................................................... -
Experiences of Using Cochrane Systematic Reviews by Local HTA Units
http://ijhpm.com Int J Health Policy Manag 2020, x(x), 1–6 doi 10.34172/ijhpm.2020.133 Short Communication Experiences of Using Cochrane Systematic Reviews by Local HTA Units Thomas G. Poder1,2* ID , Marc Rhainds3 ID , Christian A. Bellemare4 ID , Simon Deblois5 ID , Imane Hammana5 ID , Catherine Safianyk6 ID , Sylvie St-Jacques6 ID , Pierre Dagenais7,8 ID Abstract Article History: This study evaluated the use of Cochrane systematic reviews (CSRs) by Quebec’s local health technology assessment (HTA) Received: 21 November 2019 units to promote efficiency in hospital decision-making. An online survey was conducted to examine: Characteristics of Accepted: 13 July 2020 the HTA units; Knowledge about works and services from the Cochrane Collaboration; Level of satisfaction about the ePublished: 1 August 2020 use of CSRs; Facilitating factors and barriers to the implementation of CSRs evidence in a local context; Suggestions to improve the use of CSRs. Data accuracy was checked by 2 independent evaluators. Ten HTA units participated. From their implementation a total of 321 HTA reports were published (49.8% included a SR). Works and services provided by the Cochrane collaboration were very well-known and HTA units were highly satisfied with CSRs (80%-100%). As regards to applicability in HTA and use of CSRs, major strengths were as follow: Useful as resource for search terms and background material; May reduce the workload (eg, brief review instead of full SR); Use to update a current review. Major weaknesses were: Limited use since no CSRs were available for many HTA projects; Difficulty to apply findings to local context; Focused only on efficacy and innocuity; Cannot be used as a substitute to a full HTA report. -
Making Rights a Reality: Access to Health Care for Afro-Colombian Survivors of Conflict-Related Sexual Violence
MAKING RIGHTS A REALITY: ACCESS TO HEALTH CARE FOR AFRO-COLOMBIAN SURVIVORS OF CONFLICT-RELATED SEXUAL VIOLENCE Deborah Zalesne* ABSTRACT In 2008, Colombia enacted Law 1257, which states that “women’s rights are human rights,” and that women’s rights include “the right to a dignified life,” including the right to “physical health” and “sexual and reproductive health.” In 2016, the Colombian government signed a peace accord with the Revolutionary Armed Forces of Colombia (“FARC”), which included groundbreaking racial and gender justice provisions. In the years since, the government has * Professor of Law, City University of New York School of Law. B.A., Williams College; J.D., University of Denver College of Law; LL.M., Temple University School of Law. The author was a member of a delegation of faculty from the Human Rights and Gender Justice (HRGJ) Clinic at CUNY Law School that met with Afro-Colombian women activists from Proceso de Comunidades Negras (PCN) in Cali, Colombia to discuss issues concerning gender-based human rights violations committed against Afro-Colombian women since the Colombian Peace Accords. I would like to extend my gratitude to the PCN participants in this meeting for their candid and detailed recounting of personal stories of issues faced by members of their communities who have been victims of violence and for their thoughtful ideas and suggestions. I would like to thank Professor Lisa Davis, director of the HRGJ clinic, for inviting me to be a part of the delegation, and Professors Rebecca Bratspies, Babe Howell, and Julie Goldscheid, the other members of the CUNY Law delegation, for their participation in these important conversations with PCN members and for their helpful remarks about issues presented in this paper. -
Race and Ethnic Inequality in Health and Health Care in Colombia1
Race and Ethnic Inequality Raquel Bernal S. Mauricio Cárdenas S. in Health and Health Care in Colombia FEDESARROLLO WORKING PAPERS SERIES ● DOCUMENTOS DE TRABAJO Enero de 2005 ● No. 29 1 Race and Ethnic Inequality in Health and Health Care in Colombia1 Raquel Bernal Salazar Northwestern University, Evanston (U.S.) Mauricio Cárdenas Santamaría Fedesarrollo, Bogotá (Colombia) First Version: October 30th 2004 This Version: January 3rd 2005 Abstract In this paper we explore race and ethnic health inequalities in Colombia. We first characterize the situation of Afro-Colombians and indigenous populations in Colombia. Second, we document racial/ethnic disparities in health outcomes and access to health care using data from the Living Standards Survey and the evaluation of the Familias en Acción program. Third, we set up a statistical model that allows us to test whether some of the health inequalities that are observed still remain after controlling for a wide range of individual and household observed characteristics, including access to health care. The results indicate that most racial and ethnic disparities in health and access to health care disappear once we control for socioeconomic characteristics of individuals, employment status and characteristics of the job and geographic location among other things. Based on these findings we make some specific policy recommendations aimed at improving the status of racial minorities in Colombia. Key Words: Health Outcomes, Health Care, Race and Ethnicity. 1 Lucas Higuera provided excellent research assistance. We gratefully acknowledge financial support from the Inter-American Development Bank (Social Programs Division – Regional Operations Department 3) as well as useful comments from Antonio Giuffrida. -
Colombia Country Assessment/Bulletins
COLOMBIA COUNTRY ASSESSMENT October 2001 Country Information and Policy Unit CONTENTS 1. SCOPE OF DOCUMENT 1.1 - 1.5 2. GEOGRAPHY 2.1 - 2.2 3. HISTORY 3.1 – 3.38 Recent history 3.1 - 3.28 Current political situation 3.29 - 3.38 4. INSTRUMENTS OF THE STATE 4.1 – 4.60 Political System 4.1 Security 4.2 - 4.19 Armed forces 4.3 - 4.18 Military service 4.12 - 4.18 Police 4.19 - 4.28 DAS 4.29 - 4.30 The Judiciary 4.33 - 4.41 The Prison System 4.42 - 4.44 Key Social Issues 4.45 - 4.76 The Drugs Trade 4.45 - 4.57 Extortion 4.58 - 4.61 4.62 - 4.76 Kidnapping 5. HUMAN RIGHTS 5A: HUMAN RIGHTS: GENERAL ASSESSMENT A.1 – A.176 Introduction A.1 - A.3 Paramilitary, Guerrilla and other groups A.4 - A.32 FARC A.4 - A. 17 Demilitarized Zone around San Vicente del Caguan A.18 - A.31 ELN A.32 - A.48 EPL A.49 Paramilitaries A.50 - A.75 The security forces A.76 - A.96 Human rights defenders A.97 - A.111 The role of the government and the international community A.112 - A.123 The peace talks A.124 - A.161 Plan Colombia A.162 - A.176 5B: HUMAN RIGHTS: SPECIFIC GROUPS B.1 - B.35 Women B.1 - B.3 Homosexuals B.4 - B.5 Religious freedom B.9 - B.11 Healthcare system B.11 - B.29 People with disabilities B.30 Ethnic minority groups B.31 - B.46 Race B.32 - B.34 Indigenous People B.35 - B.38 Children B.39 - B.46 5C: HUMAN RIGHTS: OTHER ISSUES C.1 - C.43 Freedom of political association C.1 - C.16 Union Patriotica (UP) C.6- C.13 Other Parties C.14 - C.16 Freedom of speech and press C.17 - C.23 Freedom of assembly C.24 - C.28 Freedom of the individual C.29 - C.31 Freedom of travel/internal flight C.32 - C.34 Internal flight C.35 - C.45 Persecution within the terms of the 1951 UN Convention C.46 ANNEX A: POLITICAL, GUERRILLA & SELF-DEFENCE UNITS (PARAMILITARY) ANNEX B: ACRONYMS ANNEX C: BIBLIOGRAPHY 1. -
Is a Literature Search in the Cochrane Library Enough When Preparing
Is a literature search in the Cochrane Library enough when preparing guidelines or systematic reviews with focus on treatment outcome? Lodenius Leena, Honkanen Mari Current Care, the Finnish Medical Society Duodecim Finland [email protected] Background and objectives Figure 1. Finohta’s report 32/2008. References in Medline Usually comprehensive literature searches from many and Cochrane. different databases are conducted when preparing guidelines or health technology assessment reports. The Cochrane Library consists of six databases which include reliable high- quality information (primary and secondary information sources). In the Cochrane Library focus of the clinical information is in treatment. That is why one could presume that searching the Cochrane Library is sufficient concerning the effectiveness of treatment when preparing health technology assessment reports and guidelines. Methods The sufficiency of the Cochrane Library will be tested by a bibliometric analysis. The literature used in three technology assessment reports, recently published by the Finnish Office Ryynänen OP, Iirola T, Reitala J, Pälve H, Malmivaara A. Effectiveness of prehospital care. A systematic review. Finohta’s report 32/2008. The Finnish for Health Technology Assessment, is studied by examining Office for Health Technology Assessment. Finohta/Stakes, Helsinki 2008. the reference lists. Our aim is to find out how many ISBN 978-951-33-2200-7. ISSN 1239-6273. references used in the reports can be found in the Cochrane Figure 2. Report 16/2009 (Surgical treatment of morbid Library. We also aim to find out how many references are obesity). References in Medline and Cochrane. found in Medline but not in Cochrane. It´s likely, that the results are somewhat similar in guidelines which are limited to the effectiveness of treatment. -
The Cochrane Collaboration: Making the Results of Controlled Trials Properly Accessible Andrew Herxheimer
Postgrad Med J (1993) 69, 867 - 868 Postgrad Med J: first published as 10.1136/pgmj.69.817.867 on 1 November 1993. Downloaded from Special Article The Cochrane Collaboration: making the results of controlled trials properly accessible Andrew Herxheimer Cochrane Centre, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK The Cochrane Centre in Oxford was officially at Oxford University, the Department of Clinical opened in November 1992, and is perhaps the most Epidemiology and Biostatistics at McMaster visible part so far ofthe recently launched National University, and The Online Journal of Current Health Service Research and Development Pro- Clinical Trials2 published by the American gramme. Its task is to facilitate and extend the Association for the Advancement of Science. creation of systematic reviews of randomized con- trolled trials (RCTs) evaluating health care. It is named after Archie Cochrane (1909-1988), the How the Cochrane Centres are supporting the epidemiologist who first emphasized that reliable Collaboration information from RCTs, together with other essen- tial information, is vital for making sound The time needed to prepare valid reviews of RCTs Protected by copyright. decisions in health care and research. Most tends to be grossly underestimated. Lack of clinicians and clinical scientists who have tried to experience and time often force good scientists to review the evidence for a particular procedure or produce scientifically inadequate reviews. The treatment have felt frustrated by the difficulties of Cochrane Centres will give practical support to finding out what RCTs have been done, and of those preparing and updating reviews within the interpreting their results critically. -
El Ospital 2018 PRINT MAGAZINE
EDITORIAL CALENDAR el ospital 2018 PRINT MAGAZINE P E R M A N E N T PRINT AND DIGITAL C O N T E N T F E E D Month / Closing Management and Editorial coverage and / Special Theme General Topics Products Report Issue Date Health IT Focus or Distribution at Trade Shows • Diagnostic Imaging and Nuclear Medicine European Congress of Radiology (ECR) Cardiology and Angiology • Diagnostic and Molecular Imaging PACS, RIS, EMR and EHR image archiving • Surgery Feb./Mar. 10 2018 (Echocardiography, Catheterization, • Surgery and / or Anesthesiology and communication systems • Clinical and Hospital Management • Obstetrics, Gynecology and Women's Health Vol. 74-01 Jan Vienna, Austria. Feb. 28 to March 4, 2018 Debrillation, Monitoring, Stents) • Laboratory and Clinical diagnosis (Latest updates and market report) • Pediatrics and Neonatology Previews JPR and Hospitalar 2018 • Orthopedics, Sports Medicine and Rehabilitation • Anesthesiology JPR 2018 Apr./May. 8 Laboratory and Clinical diagnosis • Obstetrics and Gynecology OR Suite Sao Paulo, Brazil. May 3 - 6, 2018 • Emergency and Trauma • Anesthesia, Emergencies and • Planning, construction, manning and Vol. 74-02 Mar (Hematology, Microbiology, (Latest updates and market report) Hospitalar 2018 • Critical Care Medicine and Intensive Care operation of health institutions SPECIALTIES Pathology, Infectology) Intensive Care Sao Paulo, Brazil. May 15 -18, 2018 • Oncology and Radiotherapy • Diagnostic and Molecular Imaging Previa de Expomed 2018 • Clinical laboratory, pathology and blood bank • Internal medicine and subspecialties (Cardiology, Analyzers for Laboratory and POCT • Interoperability of medical equipment ExpoMed 2018 Gastroenterology, Hematology, Infectology, Jun./Jul. 7 Orthopedics and Rehabilitation • Oncology and Radiotherapy (Latest updates and market report) (Medical informatics, Telemedicine and Mexico City, Mexico. -
Colombia: COVID-19 Impact of Government Measures Briefing Note – 16 April 2020
Colombia: COVID-19 Impact of government measures Briefing Note – 16 April 2020 The first case of COVID-19 was reported in Colombia on 6 March 2020. The government has since implemented a series of containment measures to mitigate disease spread Measure Type of Measure Description and strengthen the Colombian health system. The containment measures themselves Decrees Lockdown National quarantine from 25 March to 27 April: have a secondary impact, affecting humanitarian needs among vulnerable population 457, 531 preventive isolation for all inhabitants of groups. Colombia, with exceptions for example for health The purpose of this report is to support the humanitarian response in Colombia to services and to meet basic needs. understand the following issues: Decree 457 Movement Suspension of national air travel from 25 March to How do government measures mitigate the epidemic impact • on restrictions 13 April. vulnerable population groups? Decree 412 Border closure Closure of all sea, land, and river borders from 17 • What are their factors of vulnerability in relation to the measures? March until 30 May. • Which humanitarian needs are likely to arise in the short to medium term? Social distancing All events limited to 50 participants. The primary focus of the analysis is on Colombian internally displaced people (IDPs), Venezuelan refugees and migrants, and, to a lesser extent, Colombian host Social distancing Suspension of in-person classes until 31 May. communities and Colombian returnees, although some findings and conclusions apply to broader population groups (such as low-income households in general). This report Overview of selected government measures. Sources: Government of Colombia does not present specialised health analysis and does not focus on government 06/04/2020, 23/03/2020, 16/03/2020, 16/03/2020, 08/04/2020; El Tiempo 15/03/2020.